In this segment, Dr Mohan asks Dr Mann about emerging investigational agents for the management of relapsed/refractory multiple myeloma (R/R MM) that show particular promise.
Video content above is prompted by the following:
Are there any emerging investigational agents for R/R MM management that you find particularly promising?